Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial

JAMA

Volumn 280, Issue 20, 1998, Pages 1752-1756

  March, John S ^a   Biederman, Joseph ^b   Wolkow, Robert ^c   Safferman, Allan ^c   Mardekian, Jack ^c   Cook, Edwin H ^d   Cutler, Neal R ^e   Dominguez, Roberto ^f   Ferguson, James ^k   Muller, Betty ^g   Riesenberg, Robert ^h   Rosenthal, Murray ^k   Sallee, Floyd R ⁱ   Wagner, Karen D ^j  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e CALIFORNIA CLINICAL TRIALS   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g TULANE UNIVERSITY   (United States)

^h Biobehavioral Research Center   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j University of Texas Medical Branch School of Medicine   (United States)

^k Box 3527 ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OBSESSION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TREMOR;

EID: 0032567055     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.20.1752     Document Type: Article

References (34)

1. Flament MF, Whitaker A, Rapoport JL, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988;27:764-771.
2. March J, Leonard H, Swedo S. Neuropsychiatry of pediatric obsessive compulsive disorder. In: Coffey E, Brumback R, eds. Textbook of Pediatric Neuropsychiatry. Washington, DC: APA Press. In press.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Press; 1994:417-423.
4. March J, Leonard H. Obsessive-compulsive disorder: a review of the past ten years. J Am Acad Child Adolesc Psychiatry. 1996;35:1265-1273.
5. Katz RJ, DeVeaugh-Geiss J, Landau P. Clomipramine in obsessive-compulsive disorder. Biol Psychiatry. 1990;28:401-414.
6. Tollefson GD, Rampey AH Jr, Potvin JH, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder [published erratum appears in Arch Gen Psychiatry. 1994; 51:864]. Arch Gen Psychiatry. 1994;51:559-567.
7. Rasmussen S, Goodman W, Greist J, et al. Fluvoxamine in the treatment of obsessive-compulsive disorder, a multicenter double-blind placebo controlled trial in outpatients. Am J Psychiatry. In press.
8. Wheadon D, Bushnell W, Steiner M. A fixed dose comparison of 20, 40, or 60 mg of paroxetine to placebo in the treatment of obsessive-compulsive disorder. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 1993; Honolulu, Hawaii.
9. Greist J, Chouinard G, DuBoff E, et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52: 289-295.
10. March JS, Leonard HL, Swedo SE. Pharmacotherapy of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin North Am. 1995;4:217-236.
11. Flament MF, Rapoport JL, Berg CJ, et al. Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch Gen Psychiatry. 1985;42:977-983.
12. Leonard HL, Swedo SE, Rapoport JL, et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: a double-blind crossover comparison. Arch Gen Psychiatry. 1989;46:1088-1092.
13. De Veaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry. 1992;31:45-49.
14. Leonard H, Swedo S, March J, Rapoport J. Obsessive-compulsive disorder. In: Gabbard G, ed. Synopsis of Treatments of Psychiatric Disorders. Washington, DC: American Psychiatric Press; 1996: 143-148.
15. Leonard HL, March J, Rickler KC, Allen AJ. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:725-736.
16. Feighner J, Boyer W. Selective Serotonin Reuptake Inhibitors. New York, NY: John Wiley & Sons Inc; 1991.
17. Chouinard G, Goodman W, Greist J, et al. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990;26:279-284.
18. Greist JH, Jefferson JW, Kobak KA, et al. A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995;10:57-65.
19. Riddle MA, Scahill L, King RA, et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31:1062-1069.
20. Goodman W, Rasmussen S, Foa E, Price L. Obsessive-compulsive disorder. In: Prien R, Robinson D, eds. Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. New York, NY: Raven Press; 1994:431-466.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R). Washington, DC: American Psychiatric Press; 1987.
22. Goodman WK, Price LH. Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15:861-869.
23. Scahill L, Riddle M. McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844-852.
24. Murphy D, Pickar D, Alterman I. Methods for the quantitative assessment of depressive and manic behavior. In: Burdock E, Sudilovsky A, Gershon S, eds. The Behavior of Psychiatric Subjects. New York, NY: Marcel Dekker; 1982:355-391.
25. Guy W. ECDEU Assessment Manual for Psychopharmacology. 2nd ed. Washington, DC: US Government Printing Office; 1976.
26. March J, Frances A, Kahn D, Carpenter D. Expert Consensus guidelines: treatment of obsessive-compulsive disorder. J Clin Psychiatry. 1997;58:1-12.
27. Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:559-567.
28. Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry. 1995;52:53-60.
29. Riddle M, Claghorn J, Gaffney G, et al. A Controlled Trial of Fluvoxamine for OCD in Children and Adolescents. Boca Raton, Fla: NCDEU; 1996.
30. Leonard HL, Meyer MC, Swedo SE, et al. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995; 34:1460-1468.
31. Schroeder JS, Mullin AV, Elliott GR, et al. Cardiovascular effects of desipramine in children. J Am Acad Child Adolesc Psychiatry. 1989;28:376-379.
32. Elliott G, Popper C. Tricyclic antidepressants: the QT interval and other cardiovascular parameters. J Child Adolesc Psychopharmacol. 1991;1:187-191.
33. Fisch C. Effect of fluoxetine on the electrocardiogram. J Clin Psychiatry. 1985;44:42-44.
34. March J, Mulle K. OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual. New York, NY: Guilford Press; 1998.